We are live on ! Find out more
RNAC icon

Cartesian Therapeutics
RNAC

81 hedge funds and large institutions have $174M invested in Cartesian Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $183K | Put options by funds: $79K

118% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 11

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

33% more funds holding

Funds holding: 61 → 81 (+20)

28% more capital invested

Capital invested by funds: $136M → $174M (+$37.9M)

0.16% more ownership

Funds ownership: 2.18% → 2.34% (+0.16%)

Holders
81
Holders Change
+20
Holders Change %
+32.79%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
24
Reduced
11
Closed
19
Calls
$183K
Puts
$79K
Net Calls
+$104K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$14.2M
2
BlackRock
BlackRock
New York
+$9.86M
3
MWNA
Marshall Wace North America
New York
+$8.62M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.29M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$16.9M
2
EC
EcoR1 Capital
California
-$11.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$4.09M
4
LGM
Logos Global Management
California
-$2.68M
5
Millennium Management
Millennium Management
New York
-$2.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
76
Simplex Trading
Illinois
$13K +$14.5K +160 +5,333%
TRCT
77
Tower Research Capital (TRC)
New York
$10K +$10.2K +112 New
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$7.23K +$7.61K +84 +8,400%
TWA
79
TCI Wealth Advisors
Arizona
$1K – – –
VFA
80
Valeo Financial Advisors
Indiana
$1K +$1.09K +12 New
EC
81
EcoR1 Capital
California
– -$11.1M -153,257 Closed
Citadel Advisors
82
Citadel Advisors
Florida
– -$4.09M -56,511 Closed
LGM
83
Logos Global Management
California
– -$2.68M -37,062 Closed
PVI
84
Pura Vida Investments
New York
– -$1.51M -20,825 Closed
OM
85
Opaleye Management
Massachusetts
– -$940K -13,000 Closed
Susquehanna International Group
86
Susquehanna International Group
Pennsylvania
– -$872K -9,621 Closed
BCM
87
Bridgeway Capital Management
Texas
– -$477K -6,603 Closed
Squarepoint
88
Squarepoint
New York
– -$238K -3,297 Closed
LI
89
Leap Investments
Illinois
– -$144K -1,997 Closed
ECM
90
ExodusPoint Capital Management
New York
– -$78K -1,077 Closed
SIM
91
Spark Investment Management
New York
– -$69K -963 Closed
JGC
92
J. Goldman & Co
New York
– -$69K -956 Closed
DTL
93
Dynamic Technology Lab
Singapore
– -$66K -908 Closed
Walleye Capital
94
Walleye Capital
New York
– -$59K -811 Closed
William Blair & Company
95
William Blair & Company
Illinois
– -$48K -667 Closed
Victory Capital Management
96
Victory Capital Management
Texas
– -$26K -369 Closed
Walleye Trading
97
Walleye Trading
New York
– -$27K -367 Closed
Stifel Financial
98
Stifel Financial
Missouri
– -$26K -363 Closed
Macquarie Group
99
Macquarie Group
Australia
– -$24K -329 Closed
Osaic Holdings
100
Osaic Holdings
Arizona
– +$272 +3 New
1 2 3
4

RNAC Hedge Fund Activity: Q2 2020 in Review

81 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cartesian Therapeutics (RNAC) for Q2 2020, worth a combined $174M — up 28% from $136M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new RNAC positions and 19 closed out — a net gain of 20 holders — while 24 added to existing stakes and 11 trimmed.

The largest buyer was BVF Inc, adding an estimated $14.2M. The largest seller was Vivo Capital, cutting an estimated $16.9M.

  • 81 institutional investors held Cartesian Therapeutics (RNAC) as of Q2 2020, up from 61 in Q1 2020.
  • Funds reported $174M of Cartesian Therapeutics stock for Q2 2020, up 28% quarter-over-quarter.
  • 39 funds opened new Cartesian Therapeutics positions in Q2 2020 and 19 closed out, a net change of +20 holders.
  • The largest Cartesian Therapeutics buyer in Q2 2020 was BVF Inc, an estimated $14.2M added.
  • The largest Cartesian Therapeutics seller in Q2 2020 was Vivo Capital, an estimated $16.9M sold.

Based on aggregated 13F filings for Q2 2020.